Indian Journal of Pharmacology Home 

RESEARCH ARTICLE
[View FULLTEXT] [Download PDF]
Year : 2009  |  Volume : 41  |  Issue : 5  |  Page : 213--217

The effects of pentoxifylline on skeletal muscle contractility and neuromuscular transmission during hypoxia

Fatma Simsek-Duran1, Mert Ertunc2, Rustu Onur2 
1 Department of Physiology, Faculty of Medicine, Hacettepe University, 06100 Sihhiye, Ankara, Turkey
2 Department of Pharmacology, Faculty of Medicine, Hacettepe University, 06100 Sihhiye, Ankara, Turkey

Correspondence Address:
Fatma Simsek-Duran
Department of Physiology, Faculty of Medicine, Hacettepe University, 06100 Sihhiye, Ankara
Turkey

Objectives : The objective of this study was to investigate the effects of pentoxifylline (PTX), a drug that is mainly used for indications related to tissue hypoxia, on hypoxia-induced inhibition of skeletal muscle contractility and neuromuscular transmission in mice. We hypothesized that chronic PTX treatment alters skeletal muscle contractility and hypoxia-induced dysfunction. Materials and Methods : Mice were treated with 50 mg/kg PTX or saline intraperitoneally for a week. Following ether anesthesia, diaphragm muscles were removed; isometric muscle contractions and action potentials were recorded. Time to reach neuromuscular blockade and the rate of recovery of muscle contractility were assessed during hypoxia and re-oxygenation. Results : The PTX group displayed 90% greater twitch amplitudes (P < 0.01). Hypoxia depressed twitch contractions and caused neuromuscular blockade in both groups. However, neuromuscular blockade occurred earlier in PTX-treated animals (P < 0.05). Muscle contractures developed during hypoxia were more pronounced in the PTX group (P < 0.05). Re-oxygenation reduced contracture and indirect muscle contractions resumed. The rate of recovery of contractions was faster (P < 0.05) and the amplitude of contractions was greater (P < 0.01) in the PTX group. PTX treatment increased amplitude (P < 0.05) and shortened action potential (P < 0.05) without altering resting membrane potential, excitation threshold, and neurotransmitter release. Conclusion : Chronic PTX treatment increases diaphragm contractility, but amplifies hypoxia-induced contractile dysfunction in mice. These results may implicate important clinical consequences for clinical usage of PTX in hypoxia-related conditions.


How to cite this article:
Simsek-Duran F, Ertunc M, Onur R. The effects of pentoxifylline on skeletal muscle contractility and neuromuscular transmission during hypoxia.Indian J Pharmacol 2009;41:213-217


How to cite this URL:
Simsek-Duran F, Ertunc M, Onur R. The effects of pentoxifylline on skeletal muscle contractility and neuromuscular transmission during hypoxia. Indian J Pharmacol [serial online] 2009 [cited 2019 Oct 22 ];41:213-217
Available from: http://www.ijp-online.com/article.asp?issn=0253-7613;year=2009;volume=41;issue=5;spage=213;epage=217;aulast=Simsek-Duran;type=0